A Study to Evaluate Subcutaneous Daratumumab in Combination With Standard Multiple Myeloma Treatment Regimens
Clinical trial NCT03412565 · COMPLETED
Trial details
- NCT number
- NCT03412565
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-26
- Primary completion
- 2020-08-12
- Enrollment
- 265
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.